The effect of oxytocin nasal spray on social interaction deficits observed in young children with autism: a randomized clinical crossover trial

Yatawara, C J, Einfeld, S L, Hickie, I B, Davenport, T A, Guastella, A J·2016·Molecular Psychiatry
DOI 10.1038/mp.2015.162

Cited by (346)

Items 301–346 of 346

  1. Oxytocin
    Larry J. Young, Hans H. Zingg · 2016 · Elsevier eBooks
  2. Liquid Chromatography-Mass Spectrometry Strategies for in vivo Neurochemical Monitoring with Microdialysis.
    Jenny‐Marie T. Wong · 2016 · Deep Blue (University of Michigan)
  3. Oxytocin and epigenetic mechanisms in mouse models of empathy and autism
    Marc T. Pisansky · 2016 · University of Minnesota Digital Conservancy (University of Minnesota)
  4. The Role of SNORD116 in the Neuromolecular Pathogenesis of the Prader-Willi Syndrome
    Lisa Cole · 2016
  5. Characterization of Ambra1 heterozygous mice as genetic mouse model of female-specific autism
    Anes Ju · 2017
  6. On oxytocin and social behavior
    Daniel Hovey · 2018 · Gothenburg University Publications Electronic Archive (Gothenburg University)
  7. Neural Basis of Difficulty to Understand Each Other and Trials of Oxytocin to Treat the Difficulty
    Hidenori Yamasue · 2018 · Higher Brain Function Research
  8. Neurological Differences and Pharmaceuticals in Persons with Autism
    Gwendolyn Barnhart · 2019 · International Journal Of Medical Science And Clinical Invention
  9. 自閉スペクトラム症に対するオキシトシン治療効果の医師主導Randomized Controlled Trial ─マルチモダリティ脳画像解析の応用─
    山末 英典 · 2018 · 日本生物学的精神医学会誌 = Japanese journal of biological psychiatry
  10. Studying the effects of Salvia spp. extract in a valproic-acid induced rat model of autism and its possible metabolic relevance
    Samson Guenné, Nabèrè Ouattara, Radu Marian Lefter, Daniel Vasile Timofte, Adama Hilou, Martin Kiendrébeogo · 2019 · Bulletin of Integrative Psychiatry
  11. Autism: a curse on today’s society
    Snehashis Sarkar · 2020 · Journal of Applied Pharmaceutical Research
  12. A Randomized Controlled Trial of Intranasal Oxytocin in Phelan-McDermid Syndrome
    Jarrett Fastman, Jennifer H. Foss‐Feig, Yitzchak Frank, Danielle B. Halpern, Hala Harony‐Nicolas, Christina Layton, Sven Sandin, Paige M. Siper, Lara Tang, M. Pilar Trelles et al. · 2021 · Research Square
  13. Literaturverzeichnis
    2018 · Elsevier eBooks
  14. ANAIS DA II JORNADA DE PSIQUIATRIA DE JUIZ DE FORA
    2019
  15. An overview of pharmacotherapy in the management of children diagnosed with autism spectrum disorder at a public hospital in KwaZulu-Natal, South Africa
    Jennal Maniram, Frasia Oosthuizen, Saira B. Karrim · 2022 · Research Square
  16. PHARMACOLOGICAL TREATMENT OF AUTISM SPECTRUM DISORDERS: DIRECTIONS AND PROSPECTS
    Леся Анатольевна Боднарь · 2020 · International Medical Journal
  17. Impairments in social interaction of individuals with personality disorders and dark personality traits (Beperkingen in sociale interactie van individuen met persoonlijkheidsstoornissen en donkere persoonlijkheidskenmerken)
    Haang Jeung-Maarse · 2023
  18. Anti-Inflammatory Interventions for Autism Spectrum Disorder
    Haily Holston, Avani Karvat, Simran Lallian, PingJu Wu · 2024 · Berkeley Pharma Tech Journal of Medicine
  19. Chapter 66. Treatment of Autism Spectrum Disorder
    John P. Hegarty, Antonio Y. Hardan · 2024 · American Psychiatric Association Publishing eBooks
  20. UNRAVELING THE COMPLEX GENETIC ARCHITECTURE OF AUTISM SPECTRUM DISORDER: INSIGHTS INTO PATHOPHYSIOLOGY AND THERAPEUTIC IMPLICATIONS
    Julia Coradin, Yasmin Vitória Carvalho de Castro, Fernanda Leal Caiado, Afrânio Côgo Destêfani, Vinícius Côgo Destefani · 2024 · Revista Ibero-Americana de Humanidades, Ciências e Educação
  21. Novel treatment in managing autism
    Siddhartha Das Pramanik, Yadu Nandan Dey, Dharmendra Kumar, Manju Rawat Singh, Deependra Singh · 2024 · Elsevier eBooks
  22. Psychopharmacology for Autism and Neurodevelopmental Disorders
    David Cochran, Isha R. Jalnapurkar, Alexandra C. Palmer, Lauren Venuti, Jean A. Frazier · 2024 · Springer eBooks
  23. Over-the-Counter Medications and Nutritional Supplements in Child Psychiatry
    Robert L. Hendren, Madeline I. Spiess, Felicia Widjaja · 2024 · Springer eBooks
  24. A comprehensive review on neuropeptides: databases and computational tools
    Wei Hong Xu, Lei Wang, Mingxia Wang, Jingkang Jiang, Zhidong Xue, Yan Wang · 2025 · Computational Biomedicine
  25. Individuelle biologische Interventionen bei Gewalt und Aggression. I. Psychopharmako- und Hormontherapie
    Peter Sturmey · 2025 · Springer eBooks
  26. Exploring the mechanistic link between the oxytocinergic system and mindfulness training in adults with heightened stress: study protocol for a double-blind, randomized, placebo-controlled trial (MOX-MIND)
    E. van Weert, Hendrik-Jan De Vuyst, Katleen Van der Gucht, Edward Debbaut, Jean G. Steyaert, Kaat Alaerts · 2025 · BMC Psychiatry
  27. Additional file 1 of A randomized controlled trial of intranasal oxytocin in Phelan-McDermid syndrome
    Jarrett Fastman, Jennifer H. Foss‐Feig, Yitzchak Frank, Halpern, D., Hala Harony‐Nicolas, Layton, C., Sandin, S., Paige M. Siper, L. Tang, Trelles, P. et al. · 2021 · Figshare
  28. Additional file 2 of A randomized controlled trial of intranasal oxytocin in Phelan-McDermid syndrome
    Jarrett Fastman, Jennifer H. Foss‐Feig, Yitzchak Frank, Halpern, D., Hala Harony‐Nicolas, Layton, C., Sandin, S., Paige M. Siper, L. Tang, Trelles, P. et al. · 2021 · Figshare
  29. Additional file 1 of Effects of multiple-dose intranasal oxytocin administration on social responsiveness in children with autism: a randomized, placebo-controlled trial
    Nicky Daniëls, Matthijs Moerkerke, Jean G. Steyaert, Annelies Bamps, Edward Debbaut, Jellina Prinsen, Tiffany Y. Tang, Stephanie Van der Donck, Bart Boets, Kaat Alaerts · 2024 · Figshare
  30. Complementary and Alternative Treatments for Autism Spectrum Disorder: A Comprehensive Review
    Melek Hande Bulut Demir · 2026 · Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry
  31. Preliminary Data Regarding the Potential of Oxytocin to Modulate Aggressive Behaviour in a VPA-Based Animal Model of Autism Spectrum Disorder
    Oana Georgiana Oprea, Petru Fabian Lungu, Ionut Alexandru Chelaru, Ioana-Miruna Balmuș, Roxana Jijie, Gabriel Ionut Plavan, Mircea Nicoară, Alin Ciobica, Diana Gheban, Stefan Andrei Chiriac · 2026 · Pharmaceuticals
  32. The role of the oxytocinergic system in oral microbiome composition in children with autism: evidence from a randomized controlled trial of intranasal oxytocin
    Margaux Evenepoel, Nicky Daniëls, Matthijs Moerkerke, Jellina Prinsen, Jean G. Steyaert, Bart Boets, Marie Joossens, Kaat Alaerts · 2026 · Translational Psychiatry
  33. La résistance pharmacologique dans les pathologies psychiatriques : Exemple de la dépression, la schizophrénie et l'autisme.
    Maud Rothärmel · 2019 · theses.fr (ABES)
  34. Caractérisation du long ARN non codant COSMOC dérégulé dans les troubles du spectre autistique : une approche transcriptomique sur cellules souches olfactives humaines
    Pauline Rontani · 2018 · theses.fr (ABES)
  35. Oxytocin receptors in neurodevelopmental disorders : innovative approaches for the quantification of sopramolecular receptor complexes
    Francesca Santini · 2021 · theses.fr (ABES)
  36. A pilot study on the role of the oxytocinergic system in gut microbiome composition in children with autism: baseline associations and effects of intranasal oxytocin
    Margaux Evenepoel, Elise Tuerlinckx, Muriel Derrien, Matthijs Moerkerke, Jellina Prinsen, Arnau Vich Vila, Jean G. Steyaert, Nicky Daniëls, Bart Boets, Jeroen Raes et al. · 2026 · Brain Behavior and Immunity
  37. Effets des ions bromures dans les modèles murins d'autisme et sur la signalisation des récepteurs couplés aux protéines G
    Cécile Derieux · 2021 · theses.fr (ABES)
  38. New regulators in oxytocin and vasopressin release : role of the endolysosomal two-pore channels
    Lora L. Martucci · 2021 · theses.fr (ABES)
  39. Does intranasal oxytocin reduce symptoms of mental disorders? A meta-analysis of clinical trials
    Justin N Bonnieux, Stephanie T. Gumuchian, Alexandra Harboun, Florencia Trespalacios, Kellie-Anne Bélisle, Alexandra Haddad, Olivia Quintus-Bosz, Alison McLellan, Leo Chester-Trudel, David Garred et al. · 2026 · Neuroscience & Biobehavioral Reviews
  40. Nanotechnology-Driven Drug-Delivery Systems: Mechanistic Insights for Pediatric Autism Treatment in 2026
    Mahboubeh Atashgahi, Fatemeh Madani, Thomas Jay Webster · 2026 · International Journal of Nanomedicine
  41. The Effect of Intranasal Oxytocin on Social Interaction in Adults and Children With Autism Spectrum Disorders: A Systematic Review and Meta-analysis of Randomized Controlled Trials
    Gengjing Fang, Wuyuan Pan, Guokai Li, Le Ma, Jinbao Wei · 2026 · ALPHA PSYCHIATRY
  42. Selecting the optimal study design!
    Monirah Abdulrahman Albabtain, Maha M. AlRasheed, Amr A. Arafat, Hans‐Georg Breitinger, Ulrike Breitinger, Gihan Hamdy Elsisi, Amira Gaber, Mohammed Gumaa, Menna Hozien, Ragwa Mansour Abdelghany et al. · 2026 · Elsevier eBooks
  43. BindingDB Entry 50010216: Design and Characterization of Superpotent Bivalent Ligands Targeting Oxytocin Receptor Dimers via a Channel-Like Structure.
    BindingDB · 2021 · UC San Diego
  44. BindingDB Entry 50008916: Development of a Highly Potent Analogue and a Long-Acting Analogue of Oxytocin for the Treatment of Social Impairment-Like Behaviors.
    BindingDB · 2021 · UC San Diego
  45. BindingDB Entry 50002504: LIT-001, the First Nonpeptide Oxytocin Receptor Agonist that Improves Social Interaction in a Mouse Model of Autism.
    BindingDB · 2020 · UC San Diego
  46. Psychopharmacology
    JAMES H. POWERS, Robyn Pauline Thom, Christopher J. McDougle · 2026